Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Prestige Consumer Healthcare (PBH) over the last 15 years, with Q4 2025 value amounting to $438.5 million.

  • Prestige Consumer Healthcare's Treasury Shares rose 6496.47% to $438.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $438.5 million, marking a year-over-year increase of 6496.47%. This contributed to the annual value of $277.2 million for FY2025, which is 2622.11% up from last year.
  • According to the latest figures from Q4 2025, Prestige Consumer Healthcare's Treasury Shares is $8.9 million, which was up 3954.11% from $8.1 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's Treasury Shares' 5-year high stood at $8.9 million during Q4 2025, with a 5-year trough of $4.1 million in Q1 2021.
  • Its 5-year average for Treasury Shares is $5.7 million, with a median of $5.7 million in 2023.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Treasury Shares surged by 223.05% in 2022 and then soared by 6496.47% in 2025.
  • Prestige Consumer Healthcare's Treasury Shares (Quarter) stood at $133.6 million in 2021, then surged by 41.5% to $189.1 million in 2022, then rose by 16.14% to $219.6 million in 2023, then grew by 21.04% to $265.8 million in 2024, then soared by 64.96% to $438.5 million in 2025.
  • Its Treasury Shares was $438.5 million in Q4 2025, compared to $392.2 million in Q3 2025 and $316.3 million in Q2 2025.